{"disease":{"id":"immunogenicity-and-safety-of-a-recombinant-adenovirus-type-5-vectored-covid-19-vaccine-using-for-sequential-immunization","name":"immunogenicity and safety of a recombinant adenovirus type 5 vectored covid 19 vaccine using for sequential immunization"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05373030","title":"Sequential Immunization With Recombinant Adenovirus Type-5-vectored COVID-19 Vaccine in Health Adults Based on 3 Doses Inactivated COVID-19 Vaccine","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":200,"lead_sponsor_name":"Zhejiang Provincial Center for Disease Control and Prevention","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}